Key facts
- Exposome’s last known valuation is $8.6M (Apr 2025).
- It has raised $3.4M; the latest was Later Stage VC ($2.9M) in Apr 2025.
- Notable investors include Applied Ventures, Spectrum Impact, 3iPartners, AIC Sangam Innovation Foundation, Baker Hughes Energy Ideas Generation Program — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Exposome
- ·The full record, as it builds
Funding rounds
No funding rounds for Exposome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Exposome
Manufacturer of reusable molecular filters intended for capturing air emissions and treating wastewater for industries. The company's molecular air filters leverage a chemisorptive process with a choice of media for selective removal of gaseous pollutants by utilizing antimicrobial filter fabrics and a media for the removal of dissolved contaminants from freshwater, enabling industrial sectors including pharmaceuticals, oil and gas, public utilities, electronics manufacturing, and renewable energy to manage effluent streams, recover resources, and address environmental compliance requirements.
- Sector
- Business Products and Services (B2B)
- HQ
- Mumbai, India
- Founded
- 2020
- Employees
- 26
- Website
- exposome.in/
- Ownership
- Privately Held (backing)
Exposome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exposome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exposome in its N-PORT filings yet. We sweep new filings monthly.